The decrease in positive RSV infections may be due to the introduction of immunoprophylaxis
to high-risk patients.
multocida type A to induce immunoprophylaxis
against the disease in different areas of Pakistan.
The cost implication of offering solely passive prophylaxis during intensive chemotherapy of patients with leukaemia and non-Hodgkin's lymphoma led to discontinuation of this protocol and a recommendation for simultaneous passive and active immunoprophylaxis
from the start of such therapy.
Alteration of the influences of HLA classes I and II alleles on the perinatal hepatitis B virus infection after immunoprophylaxis
in Korean children.
Risk of vertical transmission occurs in a large number of cases in the absence of immunoprophylaxis
Healthcare providers and public health officials can use information on RSV circulation to guide diagnostic testing and timing of RSV immunoprophylaxis
for children at high risk for severe respiratory infection.
is the only available measure to prevent severe RSV disease.
Now, biologists at Caltech led by Nobel Laureate David Baltimore, president emeritus and Robert Andrews Millikan Professor of Biology, have taken one step closer to that goal and have developed a new approach to HUIV prevention, called Vectored ImmunoProphylaxis
The failure of immunoprophylaxis
might be due to factors such as lack of prevailing serotypes of FMD virus in the vaccine, inappropriate amount of immunogen/ vaccine dose, lack of cold chain, concurrent disease or prevailing biological and chemical immuno-suppressants (Meyer and Knudersen, 2001).
ATLANTA -- In the wake of a Food and Drug Administration advisory panel vote against recommending licensure of a new drug for the prevention of respiratory syncytial virus, a Centers for Disease Control and Prevention working group on RSV immunoprophylaxis
will continue to develop recommendations for the use of currently available products, the group's chair said.
On the basis of these findings, the American Academy of Pediatrics Committee on Infectious Diseases and the Committee on Fetus and Newborn revised indications for use of palivizumab because the results of the 76-center study "demonstrated the safety and efficacy of monthly palivizumab immunoprophylaxis
in infants and children with hemodynamically significant congenital heart disease," Dr.
with palivizumab, a humanized respiratory syncytial virus monoclonal antibody, for prevention of respiratory syncytial virus infection in high risk infants: A consensus opinion.